ArticlePloS one2023

Field assessment of BinaxNOW antigen tests as COVID-19 treatment entry point at a community testing site in San Francisco during evolving omicron surges.

John Schrom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.